Journal of Cancer Therapy

Volume 14, Issue 2 (February 2023)

ISSN Print: 2151-1934   ISSN Online: 2151-1942

Google-based Impact Factor: 0.30  Citations  h5-index & Ranking

5-Fluorouracil-Induced Hyperammonemia Encephalopathy in a Patient with Gastric Cancer

HTML  XML Download Download as PDF (Size: 1569KB)  PP. 102-106  
DOI: 10.4236/jct.2023.142009    80 Downloads   463 Views  

ABSTRACT

Chemotherapy with 5-fluorouracil (5 FU) has been widely used to treat advanced gastric cancer. Knowing the side effects is therefore important in order to better prevent them. Fluoropyrimidine-induced hyperammonemic encephalopathy is a rare complication and characterized neurological status with elevated ammonia level without radiological abnormalities. We report the first case of 5 FU-induced hyperammonemic encephalopathy in women patients on induction chemotherapy for gastric cancer in Madagascar. His ammonia level (NH3) was 102 μmol/l. The patient recovered from his confusional state after two days of treatment with hyperhydration and vitamin therapy.

Share and Cite:

Rakotoarivo, T. , Andrianarison, V. , Andrianandrasana, N. , Razakanaivo, M. and Rafaramino, F. (2023) 5-Fluorouracil-Induced Hyperammonemia Encephalopathy in a Patient with Gastric Cancer. Journal of Cancer Therapy, 14, 102-106. doi: 10.4236/jct.2023.142009.

Cited by

No relevant information.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.